These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 182355)

  • 1. Management of small cell carcinoma of the lung: therapy, staging, and biochemical markers.
    Abeloff MD; Ettinger DS; Baylin SB; Hazra T
    Cancer; 1976 Sep; 38(3):1394-401. PubMed ID: 182355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy in oat cell carcinoma of the lung.
    Nixon DW; Carey RW; Suit HD; Aisenberg AC
    Cancer; 1975 Sep; 36(3):867-72. PubMed ID: 171056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
    Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
    Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
    Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
    Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy.
    Glick JH; Barnes JM; Ezdinli EZ; Berard CW; Orlow EL; Bennett JM
    Blood; 1981 Nov; 58(5):920-5. PubMed ID: 7028181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy and radiation therapy for small cell carcinoma of the lung.
    Maurer LH; Tulloh M; Eagan RT; Forcier RJ; House R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):171-6. PubMed ID: 4354041
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive induction therapy for small cell carcinoma of the lung.
    Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE
    Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality treatment for oat cell carcinoma of the lung: a randomized trial 1,2,3.
    Alexander M; Glatstein EJ; Gordon DS; Daniels JR
    Cancer Treat Rep; 1977; 61(1):1-6. PubMed ID: 193642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and radiotherapy in small-cell carcinoma of the lung.
    King GA; Comis R; Ginsberg S; Goldberg J; Dale HT; Brown J; Dalal P; Chung C; Gottlieb A
    Radiology; 1977 Nov; 125(2):529-30. PubMed ID: 198846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide, vincristine and sequential split-course radiotherapy in the treatment of small cell lung cancer.
    Holoye PY; Samuels ML
    Chest; 1975 Jun; 67(6):675-9. PubMed ID: 165045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for small cell carcinoma of the lung: evaluation of four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine.
    Ohnoshi T; Hiraki S; Nakata Y; Machida K; Fujii M; Nakata Y; Murakami N; Miyake K; Harada J; Ozawa S; Seto T; Tamura T; Kimura I
    Acta Med Okayama; 1983 Apr; 37(2):147-53. PubMed ID: 6307001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with vincristine, adriamycin, and procarbazine in previously treated patients with small cell carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Bull M; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):485-7. PubMed ID: 194693
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination chemotherapy of advanced lung cancer: a randomized trial.
    Hansen HH; Selawry OS; Simon R; Carr DT; van Wyk CE; Tucker RD; Sealy R
    Cancer; 1976 Dec; 38(6):2201-7. PubMed ID: 187312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
    Eridani S; Burdick L; Maggio L; Cunietti E; Periti M; Arosio A; Perrone G
    Int J Clin Pharmacol Biopharm; 1978 Oct; 16(10):482-5. PubMed ID: 81190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined modality treatment of small cell carcinoma of the lung.
    Feld R; Pringle JF; Evans WK; Keen CW; Quirt IC; Curtis JE; Baker MA; Yeoh JL; Deboer G; Brown TC
    Arch Intern Med; 1981 Mar; 141(4):469-73. PubMed ID: 6260048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell anaplastic carcinoma of lung. Reappraisal of current management.
    Choi CH; Carey RW
    Cancer; 1976 Jun; 37(6):2651-7. PubMed ID: 949683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
    Harrison DT; Neiman PE
    Cancer Treat Rep; 1977 Aug; 61(5):789-95. PubMed ID: 329978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.